IQVIA Holdings Inc. (IQV) Presents at UBS Global Healthcare Conference 2025 Transcript

Financial Performance - The company reported third quarter financial results at the high end of its guidance, indicating strong performance [1] - Guidance for the remainder of the year suggests over 5% revenue growth [1] Business Development - The company booked $2.6 billion in new business within its clinical segment during the third quarter, reflecting a healthy book-to-bill ratio of 1.15 [2] - There was a significant increase in request for proposals, which rose by 20% in dollars year-over-year [3] Market Trends - Decision timelines in the industry have started to normalize after a period of uncertainty, suggesting a recovery in the market [3] - The company believes that the end of 2024 and the beginning of 2025 likely represent the trough of the recent cycle [3]